Mereo BioPharma Group plc PDMR Notification (1267W)

TIDMMPH

RNS Number : 1267W

Mereo BioPharma Group plc

14 August 2020

Mereo BioPharma Group plc

PDMR Notification

London and Redwood City, Calif ., August 14, 2020 - Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), "Mereo" or "the Company", a clinical-stage biopharmaceutical company focused on oncology and rare diseases, received notification that on August 12, 2020 John Richard, Head of Corporate Development of Mereo, purchased 3,500 American Depositary Shares (ADSs) at a price of USD 2.76 per ADS.

The below announcement and notification is made in accordance with the EU Market Abuse Regulation. The form required under the EU Market Abuse Regulation follows.

 
 1    Details of the person discharging managerial responsibilities 
 a)   Name                      John Richard 
     ------------------------  -------------------------------------------------- 
 2    Reason for the notification 
     ---------------------------------------------------------------------------- 
 a)   Position/status           Head of Corporate Development 
     ------------------------  -------------------------------------------------- 
 b)   Initial notification/     Initial notification 
       Amendment 
     ------------------------  -------------------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------------------- 
 a)   Name                      Mereo BioPharma Group plc 
     ------------------------  -------------------------------------------------- 
 b)   LEI                       213800U8JQHIJOS5AS09 
     ------------------------  -------------------------------------------------- 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     ---------------------------------------------------------------------------- 
 a)   Description of            AMERICAN DEPOSITARY SHARE (ADS) EACH REPRESENTING 
       the financial             5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES 
       instrument, type          OF GBP0.003 EACH 
       of instrument 
       and identification 
       code 
     ------------------------  -------------------------------------------------- 
 b)   Nature of the             PURCHASE 
       transaction 
     ------------------------  -------------------------------------------------- 
 c)   Price(s) and                Price(s)    Volume(s) 
       volume(s)                   USD 2.76    3,500 
                                              ---------- 
     ------------------------  -------------------------------------------------- 
 d)   Aggregated information: 
       volume, Price 
     ------------------------  -------------------------------------------------- 
 e)   Date of the transaction   2020-08-12 
     ------------------------  -------------------------------------------------- 
 f)   Place of the              XNMS (Nasdaq Global Market) 
       transaction 
     ------------------------  --------------------------------------------------

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHGGGDIDDBDGGS

(END) Dow Jones Newswires

August 14, 2020 02:00 ET (06:00 GMT)

Mereo Biopharma (LSE:MPH)
Historical Stock Chart
From May 2024 to Jun 2024